March 30, 2025 - 01:14

In a recent discussion on CNBC's Squawk on the Street, financial commentator Jim Cramer addressed the current state of Micron Technology, Inc. and its position in the broader tech market. Cramer expressed his confusion over the recent fluctuations affecting Micron's stock, which has been a topic of concern among investors.
He highlighted the challenges facing the semiconductor industry, particularly amid a backdrop of economic uncertainty and shifting demand patterns. Cramer emphasized that while Micron has been a prominent player in the memory chip market, its performance has been impacted by various external factors, making it difficult to predict future trends.
Cramer’s commentary comes at a time when many tech stocks are experiencing volatility, leaving investors seeking clarity on where to allocate their resources. As Micron navigates these turbulent waters, Cramer’s insights may provide a valuable perspective for those watching the tech sector closely. The ongoing developments in the semiconductor space will be crucial for understanding Micron's trajectory in the coming months.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...